知名学者引用


        除了所发表论文的被引用频次、期刊质量能够彰显学者的学术影响力以外,被知名学者引用也是一项学术评价的重要指标。
        当前同舟云学术认定的知名学者包括:诺贝尔奖、菲尔兹奖、图灵奖等奖项获得者,多个国家的院士,同舟云学术“2023全球学者学术影响力排行版”入榜的前10万学者等。

Zhang, Xi 中山大学被知名学者引用:330人次(黄金会员以上可以申请导出本人论文被全部知名学者引用的数据)

1. Fleisher, Lee A. 美国 University of Pennsylvania School of Medicine 2007美国医学院院士 2020 ACC/AHA guideline for the management of patients with valvular heart disease

2. Fleisher, Lee A. 美国 University of Pennsylvania School of Medicine 2007美国医学院院士 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease

3. 周宏灏 中国 中南大学 中国工程院院士 Precision dosing of warfarin: open questions and strategies

4. Serpil C,Erzurum 美国 LERNER Research Institute 2017美国医学院院士 Injury-Induced Shedding of Extracellular Vesicles Depletes Endothelial Cells of Cav-1 (Caveolin-1) a..

5. Mukul Sharma 美国 University of Texas at Austin 2018美国工程院院士 Canadian stroke best practice consensus statement: Secondary stroke prevention during pregnancy

6. Judith,Therrien 加拿大 MCGILL University Risk of cardiovascular events after influenza infection-related hospitalizations in adults with cong..

7. Squizzato, Alessandro 意大利 University of Insubria Anticoagulant Therapy in Pregnant Women with Mechanical Heart Valves: Italian Federation of Centers ..

8. 崔庆华 中国 武汉体育学院 教授 Aging aggravates aortic aneurysm and dissection via miR-1204-MYLK signaling axis in mice

9. 张春祥 中国 西南医科大学 主任医师 Aging aggravates aortic aneurysm and dissection via miR-1204-MYLK signaling axis in mice

10. Emad,Kandil 美国 Tulane University Reviving ancient therapeutics in modern medicine: an immunological and biological narrative review o..

11. Steve R,Ommen 美国 Mayo Clinic - Rochester 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy

12. Christopher,Semsarian 澳大利亚 University of Sydney 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy

13. Joseph A,Dearani 美国 Mayo Clinic - Rochester 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy

14. Christopher,Semsarian 澳大利亚 University of Sydney 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Rep..

15. Joseph A,Dearani 美国 Mayo Clinic - Rochester 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Rep..

16. Steve R,Ommen 美国 Mayo Clinic - Rochester 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Rep..

17. Edit I,Buzas 匈牙利 Semmelweis University Effect of hypercholesterolemia on circulating and cardiomyocyte-derived extracellular vesicles

18. Peter,Ferdinandy 匈牙利 Semmelweis University Effect of hypercholesterolemia on circulating and cardiomyocyte-derived extracellular vesicles

19. Kasey C,Vickers 美国 VANDERBILT University Antiinflammatory Effect of High-Density Lipoprotein Blunted by Delivery of Altered MicroRNA Cargo in..

20. Antoni,Bayes-Genis 西班牙 Hospital Universitari Germans Trias i Pujol Multidisciplinary care of peripartum heart failure: A scientific statement of the Heart Failure Asso..

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3